首页> 外文期刊>Journal of cataract and refractive surgery >Pupil dilation with intracameral lidocaine during phacoemulsification.
【24h】

Pupil dilation with intracameral lidocaine during phacoemulsification.

机译:白内障超声乳化术中使用小学生利多卡因散瞳。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To evaluate pupil dilation by an intracameral injection of nonpreserved lidocaine 1% during phacoemulsification cataract extraction and compare the results with those using conventional topical mydriatics. SETTING: Department of Ophthalmology, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran. METHODS: A prospective comparative case series study was conducted. The study included 57 patients who were given topical mydriatics (30 eyes) or intracameral lidocaine (27 eyes) to dilate the pupil for phacoemulsification and intraocular lens implantation. The topical group received 3 drops of cyclopentolate 1% and phenylephrine 5% given 5 minutes apart starting 60 minutes before surgery. The intracameral group received preservative-free lidocaine 1% (0.2 to 0.3 mL) injected just before the procedure began. No epinephrine was added to the irrigating solution. In both groups, the horizontal pupil diameter was measured before and after pupil dilation using the same caliper. Total surgical time, need for a mydriatic agent during the procedure, and subjective surgical performance were recorded. RESULTS: The mean age, sex, cataract density, baseline horizontal pupil diameter, and mean duration of the surgery were the same between the topical group and intracameral group. The mean pupil dilation was 4.52 mm +/- 0.08 (SD) in the intracameral group and 4.06 +/- 0.09 mm in the topical group; the difference between groups was statistically significant (P = .001). There was no significant difference between groups in the overall subjective surgical performance (P = .74). No patient in the intracameral group and 2 patients in the topical group required an intracameral mydriatic injection. CONCLUSION: During phacoemulsification, intracameral preservative-free lidocaine 1% provided rapid, effective mydriasis comparable that of topical mydriatics.
机译:目的:在超声乳化白内障摘除术中,通过前腔内注射未保存的1%利多卡因来评估瞳孔扩张,并将结果与​​使用常规局部散瞳的结果进行比较。单位:伊朗医学大学,伊朗德黑兰,Rassoul Akram医院眼科。方法:进行了前瞻性比较病例系列研究。该研究包括57名接受局部散瞳术(30只眼)或前房内利多卡因(27只眼)以扩大瞳孔以进行超声乳化和人工晶状体植入的患者。从手术前60分钟开始,局部组每5分钟给予3滴1%的环戊酸酯和5%的去氧肾上腺素。前房组在手术开始前就注射了1%的不含防腐剂的利多卡因(0.2至0.3 mL)。没有将肾上腺素添加到冲洗液中。在两组中,均使用相同的测径器在瞳孔扩张前后测量水平瞳孔直径。记录总手术时间,手术期间是否需要散瞳剂以及主观手术表现。结果:局部治疗组和前房内治疗组的平均年龄,性别,白内障密度,基线水平瞳孔直径和平均手术时间相同。前房组的平均瞳孔扩张为4.52 mm +/- 0.08(SD),局部组的平均瞳孔扩张为4.06 +/- 0.09 mm;两组之间的差异具有统计学意义(P = .001)。两组之间的主观手术总体表现无显着差异(P = 0.74)。前房组中无患者,外用组中有2名患者需要前房内散瞳注射。结论:在超声乳化术中,无局部防腐剂的利多卡因1%可提供与局部散瞳药相当的快速有效散瞳。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号